Under the terms of the agreement, WellSpan physicians will serve as adjunct professors at the university and gain access to the technology at the Maryland Proton Treatment Center in Baltimore. Physicians will also collaborate with university faculty on radiation research.
The treatment center specializes in proton therapy, an image-guided therapy used to treat cancer. Officials claim the radiation used in proton therapy better targets tumors, reducing an individual’s exposure to radiation and thereby reducing damage to critical organs and the surrounding healthy tissue, according to the article.
“WellSpan Health is very excited to be one of the first collaborative partners with the new Maryland Proton Treatment Center,” said Douglas Arbittier, MD, vice president of the oncology service line at WellSpan Health.
More articles on transactions and valuations:
DOD awards Medline 3 contracts for clinical products
WellCare Health Plans to buy Universal American for $600M
Fitch: Offshore, private equity firms buying into healthcare
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.